Wellness Clinic Hervey Bay

11/08/2026

05/08/2026

The macrophage doesn't just clean up debris — it reports what it finds. Every threat it destroys gets flagged to the rest of your immune system, turning simple disposal into intelligence-gathering.

Your body's janitor is also its informant.

25/07/2026

Your muscle rebuilds in about three months. Your tendons and cartilage take roughly a year and a half. Your bone, up to two years. Adding 40 grams of whey daily for two weeks doesn't change any of those timelines.

That's the finding from a study published this month in the American Journal of Clinical Nutrition. The team measured rebuild rates across more than a dozen knee tissues in living older adults using a safe heavy-water tracer. Tissues sampled during routine knee replacement surgery. Half the participants kept their habitual diet. Half added 40 grams of whey daily for 14 days. At the end, the rebuild rates of every tissue were the same in both groups.

The hierarchy was dramatic.
Muscle rebuilt at about 1.2 percent per day. At that rate, your quadriceps theoretically turn over in roughly three months. Synovium, the membrane that lines the joint capsule, rebuilt at 0.8 percent per day. The fat pad behind your kneecap, about 0.5 percent. The cruciate ligaments deep in the knee, about 0.45 percent. The patellar tendon, the femoral cartilage, and the menisci all rebuilt at 0.18 to 0.21 percent per day, putting their full-pool turnover at roughly 1.3 to 1.5 years. Bone rebuilt at 0.12 to 0.21 percent per day across five sites, with the slowest taking up to 2.3 years for a complete cycle.

What this does and does not say.
It does not say protein doesn't build connective tissue. It does. Every tissue in your body depends on dietary amino acids as substrate, and the synthesis rates measured here confirm that all of these tissues are actively turning over. Bone is a living tissue that constantly remodels. Cartilage maintains itself, slowly. Tendons repair from training and from daily mechanical load, slowly.
What the study shows is that for these older adults on their normal diets, adding 40 grams of whey on top for two weeks did not accelerate the rebuild rate of any tissue measured. It is one trial. It is small and short. It cannot rule out effects in people with inadequate baseline intake, or effects that might appear with longer supplementation. What it does establish is that connective tissue synthesis rates are dramatically slower than muscle, and a two-week protein bump does not compress those rates.

That has direct implications for what protein supplementation is and isn't doing.
Protein supplementation is a tool for closing intake gaps and for hitting the per-meal threshold that maximizes muscle protein synthesis after training. It's effective at those goals. People who are not eating enough total protein, or who are not getting enough per meal to drive muscle protein synthesis in older muscle that has lost some sensitivity to amino acids, benefit from supplementation. That's well established and not in dispute.

Protein supplementation is not a connective tissue repair accelerator. Cartilage damage from running mileage, tendon overuse injuries, bone density loss in postmenopausal women, ACL rehabilitation timelines: none of these can be hurried with whey. The biology runs at its own clock speed regardless of how much you put in.

What this means in practice.
For training and recovery, the protein protocol that has actually been shown to work is unchanged. Roughly 1.6 grams per kilogram of body weight per day, spread across three or four meals, each meal hitting at least 0.4 grams per kilogram. Training stimulus and adequate sleep do the heavy lifting on muscle adaptation. Supplemental protein at the meal level helps people hit those thresholds, especially for older adults, vegetarians, and anyone with a small appetite.

For connective tissue, the levers are different. Mechanical load through progressive training is the dominant signal for tendon and ligament adaptation. Resistance training drives bone density gains. Cartilage health responds to weight management and joint loading more than to nutrition. Collagen and vitamin C combined before training has interesting data for tendon collagen synthesis, but the effect sizes are modest. None of these tissues respond meaningfully to a protein bolus in a two-week window the way muscle does after a single training session.

The bigger reframe.
We have been treating tissue protein synthesis like a single dial. The reality is that your body runs many tissue clocks at very different speeds. Muscle is the fast one. Most of what we call "tissue building" outside of muscle takes 1 to 2 years per cycle, not days. When you injure a tendon at 55, the rehab timeline is set by how fast that tendon can lay down new collagen. Mechanical load and time do the work. Adequate protein supports it but doesn't compress the timeline.

Muscle responds to protein on a short timescale. Everything else responds on a long one. The two are not interchangeable.

Houtvast et al., Am J Clin Nutr, 2026
Moore et al., J Gerontol A, 2015
Morton et al., Br J Sports Med, 2018
Bauer et al., J Am Med Dir Assoc, 2013
Shaw et al., Am J Clin Nutr, 2017

21/07/2026

12/07/2026

10,000 liters of air. 7,000 liters of blood. 300 million alveoli. Processing oxygen continuously, every second, for 37 trillion cells. Massive infrastructure you never notice keeping you alive. Your lungs.

09/07/2026

You have heard that fructose causes fatty liver. That part is true. What is less known is that your gut gets the first attempt at clearing it, and that step can be changed.

Fructose is broken down by your gut and your liver. In excess, the liver converts it into new fat, and over time that becomes fatty liver disease. The usual advice is to cut the sugar.

A 2025 study in mice found a second lever: Researchers fed the animals the fibre inulin and used a labeled tracer to follow where the fructose went.

The fibre did not change how much fructose reached the gut. It did not change how the mouse itself processed sugar. It changed the bacteria.

Fed inulin, the gut microbiome broke fructose down in the small intestine before it could spill over to the liver. Same fructose in, far less reaching the liver. A key species behind this was Bacteroides acidifaciens, and the effect transferred through the microbiome alone.

In these mice, the result was less liver fat, better insulin sensitivity, and reduced fibrosis.

This is a mouse study. No human trial has tested it. Fibre is good for people for many reasons, but this specific mechanism, gut bacteria intercepting fructose before the liver sees it, has not been shown in humans.

Fatty liver is not only about how much sugar you eat. It is about which microbes meet that sugar first. The fibre is not feeding you. It is feeding the bacteria that clear your sugar.

Jung et al., Nature Metabolism, 2025

04/07/2026

Two people can log the same seven hours of sleep and carry different cardiovascular risk, and the variable that separates them is not how long they slept but how consistent their timing was from night to night.

Researchers tracked 72,269 UK adults with wrist accelerometers for a week, scored each person's sleep regularity with a validated index that captures how closely their sleep-wake timing repeats day to day, then followed them for eight years of hospitalization and death records. The people whose bedtimes and wake times scattered across the week had a 26% higher rate of major adverse cardiovascular events, meaning heart attack, stroke, and heart failure combined, than the people who kept a consistent schedule.

The finding that gives this study its weight is what happened when the researchers accounted for sleep duration. The intuitive assumption is that irregular sleepers are simply sleeping less, and that fixing the hours would fix the risk. It didn't. Among irregular sleepers who met the recommended amount of sleep for their age, the elevated risk barely moved, still running 19% above regular sleepers. Adequate duration offset the risk for the moderately irregular group, whose excess risk became statistically indistinguishable from zero once they slept enough, but for the genuinely irregular, hitting the hours was not a rescue. The timing itself carried the hazard.

Nearly every cardiovascular system runs on a daily clock, blood pressure, heart rate, cortisol, and the autonomic balance between sympathetic and parasympathetic tone all rise and fall on a roughly 24-hour rhythm anchored by consistent behavior. When sleep timing shifts night to night, the central clock and the peripheral clocks in cardiovascular tissue fall out of alignment with each other and with the external day, a state analogous to the physiology of shift work and social jet lag, both of which carry their own established cardiovascular associations. A person sleeping seven hours from midnight to seven one night and three in the morning to ten the next is repeatedly resetting that system, and duration alone does not capture that cost.

This is an observational cohort, so irregular timing cannot be declared a cause of cardiac events; it may partly mark people whose lives are already disrupted by illness, stress, pain, or unrecognized disease that independently raises risk, and no observational design fully removes that possibility. Sleep was captured in a single week of accelerometry and treated as representative of long-term habit, which it may not be. The cohort skewed older, healthier, and less diverse than the general population, as UK Biobank does. And the Sleep Regularity Index is a composite score, so a low number can arise from several different timing patterns that may not carry identical biological weight.

What the evidence supports, stated conservatively, is that consistency of sleep timing is associated with cardiovascular risk independently of how many hours are slept, and that among people with genuinely irregular schedules, sleeping enough does not appear to neutralize the risk their timing carries. What it does not support is a promise that regularizing your bedtime will lower your personal event rate, because demonstrating that requires an intervention trial rather than a cohort. The practical reframe is still worth stating: sleep advice overwhelmingly targets duration, the number of hours, while the timing consistency that this study flags as an independent risk factor is the lever most people never think to pull. The open question is whether deliberately stabilizing sleep timing changes hard cardiovascular outcomes, or whether regularity is simply a marker of the healthier life that produces it.

Chaput et al., J Epidemiol Community Health 2025
Vetter et al., Circulation 2016
Huang & Redline, Diabetes Care 2019

29/06/2026

There is a spinal cord disease that looks exactly like B12 deficiency, responds to none of the things B12 deficiency responds to, and is missed because the B12 test comes back normal. It is caused by a copper deficiency, and the case literature on it is young: copper deficiency myelopathy was only described as a distinct entity within the last decade, even though acquired copper deficiency has been recognized as a cause of anemia and neutropenia for more than fifty years. A 2010 review pulled together 55 published cases, and the clinical picture it assembled is a lesson in how a deficiency hides behind the wrong test.

Copper is a required cofactor for enzymes the body cannot run without, and two of those jobs explain the entire syndrome. Copper-dependent enzymes are needed to move iron through the body and to maintain the myelin that insulates nerves. Run low on copper and you get an anemia that iron supplementation will not correct, because the problem was never a shortage of iron, and you get a degeneration of the spinal cord that mirrors the subacute combined degeneration of B12 deficiency. The review states it plainly: copper deficiency myelopathy closely mimics the B12 lesion. The cord damage shows up in the same place, the posterior and lateral columns, and produces the same loss of position sense and coordination.

The diagnostic trap is that the look-alike tests read normal. In a copper-deficient patient with this myelopathy, serum B12 can be entirely normal and iron studies can be unremarkable, so the two deficiencies a clinician would reflexively check for are both ruled out, and the patient is told their bloodwork is fine while the cord damage continues. The hematology offers the first real clue. Cytopenias were present in 78 percent of the reviewed cases, anemia in particular, and the picture has been mistaken for a myelodysplastic syndrome in the past. What actually confirms the diagnosis is measuring copper directly: low serum copper and low ceruloplasmin, the copper-carrying protein. Those are the two values that close the case, and they are not on a standard anemia or neuropathy workup unless someone thinks to order them.

The reason copper deficiency is rising is mechanical, and it sits in the gut. The dominant risk factors are all things that block copper absorption in the upper gastrointestinal tract: previous upper GI surgery, malabsorption syndromes, and zinc overload, since excess zinc induces a gut protein that traps copper and carries it out in shed intestinal cells. This is why the condition is expected to become more common as bariatric surgery becomes more common, and it is more frequent in women, with a female-to-male ratio of 3.6 to 1 in the reviewed cases. In 20 percent of cases no cause was ever established, which is its own warning that the deficiency can arrive without an obvious trigger.

Copper supplementation reliably corrects the hematologic abnormalities, the anemia and the low counts come back to normal. The neurological recovery is the harder story: across the reviewed cases, treatment led to improvement or stabilization, but neurological recovery was only ever partial. The cord damage that has already happened does not fully reverse. That asymmetry, fixable blood and only partially fixable nerve, is the entire clinical argument for vigilance, because the cost of missing it is measured in the function that does not come back. The takeaway is narrow and worth stating precisely: an iron-resistant anemia paired with a B12-type myelopathy and normal B12 should prompt a copper and ceruloplasmin check, and the sooner it is caught, the more of the nervous system can be saved.

Jaiser SR, Winston GP. Copper deficiency myelopathy. J Neurol. 2010.